Short answer
VIEMED HEALTHCARE, INC. (VMD) filed an 8-K current report with the SEC on March 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events). Q4 and full-year 2025 earnings released March 4, 2026: full results in Exhibit 99.1 press release.
VIEMED HEALTHCARE, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings released March 4, 2026: full results in Exhibit 99.1 press release
- Financial Supplement with additional detail available in Exhibit 99.2
Item 7.01 · Regulation FD Disclosure
- Board approved new share repurchase program, announced March 4, 2026
- Full program details (size, duration, execution terms) contained in referenced press release exhibit: key figures not reproduced in this item
Item 8.01 · Other Events
- Board approved share buyback program on March 4, 2026, authorizing repurchase of up to 1,930,131 common shares
- Repurchases via open market, block purchases, or other methods compliant with Rule 10b-18
- ~1.93M shares authorized signals management confidence in valuation and provides potential EPS accretion
- No dollar cap or expiration date disclosed: pace and timing dependent on market price and available funds
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other VIEMED HEALTHCARE, INC. 8-K filings
Get the next VMD 8-K as it lands
Follow VMD for push alerts, or ask the research agent what this filing means.